Research News and Research

RSS

LGBTQ+ people relive old traumas as they age on their own

Bill Hall, 71, has been fighting for his life for 38 years. These days, he's feeling worn out.

24 Dec 2024

New insights into the developmental trajectory of social behaviors in fragile X syndrome

In a comprehensive Genomic Press Interview, researchers from the University of Texas Health Science Center at San Antonio and Hirosaki University have uncovered critical new insights into the developmental trajectory of social behaviors in fragile X syndrome, the leading genetic cause of autism spectrum disorder.

24 Dec 2024

Luxembourg signs historic partnership agreement with WHO to support global health

20 December 2024 was a crucial moment for Luxembourg in supporting WHO and strengthening global public health, to make progress towards the Sustainable Development Goals in 2025–2028.

24 Dec 2024

Professor Inga Neumann advances understanding of oxytocin and social fear

In a comprehensive Genomic Press Interview, Professor Inga Neumann, Chair of the Department of Behavioural and Molecular Neurobiology at the University of Regensburg, reveals groundbreaking insights into how oxytocin shapes social behavior and emotional responses in the brain.

24 Dec 2024

Can drinking coffee or tea help prevent head and neck cancer?

In a recent analysis of data from more than a dozen studies, coffee and tea consumption was linked with lower risks of developing head and neck cancer, including cancers of the mouth and throat. The findings are published by Wiley online in CANCER, a peer-reviewed journal of the American Cancer Society.

24 Dec 2024

AMF at SLAS 2025: Precision microfluidics in San Diego

AMF is excited to participate in the SLAS 2025 International Conference & Exhibition, taking place from January 25-29, 2025 at the San Diego Convention Center. This renowned event will bring together professionals from across the life sciences, biotech, and automation industries to showcase the latest innovations and technologies.

From Advanced Microfluidics SA 24 Dec 2024

New research supports more liberal blood transfusion approach for heart attack patients

Giving more blood to anemic patients after a heart attack may save lives, according to a Rutgers Health–led study.

23 Dec 2024

SPLICER shows promise in Alzheimer's and other diseases

A new gene editing tool that helps cellular machinery skip parts of genes responsible for diseases has been applied to reduce the formation of amyloid-beta plaque precursors in a mouse model of Alzheimer's disease, researchers at the University of Illinois Urbana-Champaign report.

23 Dec 2024

New MRI method may predict heart disease risk by analyzing heart fat

Everyone knows the health risks of carrying too much fat around the waist and hips, but UVA Health scientists are developing a noninvasive way to assess the health risks of unseen fat around the heart.

23 Dec 2024

Anti-TNF drugs proven to prevent perianal fistulas in Crohn's Disease

Early treatment of pediatric Crohn's disease with anti-tumor necrosis factor medications can substantially reduce the risk of perianal fistulas, a particularly debilitating complication of Crohn's disease.

23 Dec 2024

Twelve factors to protect brain health in the New Year

Improving your brain health in the new year can start with a simple step, talking with your neurologist or primary care physician about 12 factors to protect your brain.

23 Dec 2024

RSV vaccine acceptance grows amidst rising flu concerns

A year after becoming available, vaccines to protect against RSV in newborns and older adults are being more widely accepted by the American public, according to a new Annenberg Public Policy Center (APPC) health survey conducted in November 2024.

23 Dec 2024

New migraine drug atogepant shows quick relief

A drug recently approved to prevent migraine may start working right away, according to a study published in the December 23, 2024, online issue of Neurology, the medical journal of the American Academy of Neurology.

23 Dec 2024

COVID-19 infection not associated with worsening MS symptoms or disability

For people with multiple sclerosis (MS), having a COVID-19 infection is not associated with worsening MS symptoms or disability, according to a study published in the December 23, 2024, online issue of Neurology, the medical journal of the American Academy of Neurology.

23 Dec 2024

Researchers identify key mechanism linking brain stress to Alzheimer's disease

Researchers with the Advanced Science Research Center at the CUNY Graduate Center (CUNY ASRC) have unveiled a critical mechanism that links cellular stress in the brain to the progression of Alzheimer's disease (AD).

23 Dec 2024

Study highlights geographical and hospital type trends in hospital-at-home participation

Hospitals that have adopted the Center for Medicare and Medicaid (CMS) "hospital-at-home" program, which serves as an alternative to admission to brick-and-mortar facilities, are concentrated in large, urban, not-for-profit, and academic hospitals, new research suggests.

23 Dec 2024

ED physicians’ admission rates do not translate to better patient health outcomes

Patients in emergency departments who are treated by physicians with a high propensity to admit those they see into the hospital are more likely to be discharged after only a short stay, suggesting a possible unnecessary admission, while they are no less likely to die, new research suggests.

23 Dec 2024

Study reveals health impacts of returning to smoke-damaged homes

Six months after the Marshall Fire destroyed more than 1,000 houses in Boulder County, Colo., more than half of residents of surviving homes in the area reported physical symptoms - including headaches, sore throats or a strange taste in their mouth - that they attributed to poor air quality, a new CU Boulder study has found.

23 Dec 2024

Groundbreaking brain atlas sheds light on neural pathways for movement

Signals relayed to motor neurons from the brain enable muscle movement, but these signals typically pass through spinal interneurons before they reach their destination.

23 Dec 2024

New SIMPL2 platform revolutionizes the study of protein-protein interactions

A team led by researchers at the University of Toronto has created a platform, called SIMPL2, that revolutionizes the study of protein-protein interactions by simplifying detection while improving measurement accuracy.

23 Dec 2024